Unexpected guests in the tumor microenvironment: microbiome in cancer.
10.1007/s13238-020-00813-8
- Author:
Abigail WONG-ROLLE
1
;
Haohan Karen WEI
2
;
Chen ZHAO
3
;
Chengcheng JIN
4
Author Information
1. Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, National Institutes of Health, 4 Memorial Drive, Bethesda, MD, 20892, USA.
2. Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd., Philadelphia, PA, 19104, USA.
3. Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, National Institutes of Health, 4 Memorial Drive, Bethesda, MD, 20892, USA. chen.zhao@nih.gov.
4. Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd., Philadelphia, PA, 19104, USA. Chengcheng.Jin@Pennmedicine.upenn.edu.
- Publication Type:Review
- Keywords:
cancer immunotherapy;
immune system;
lung cancer;
microbiome;
tumor;
tumor-associated microbiota
- From:
Protein & Cell
2021;12(5):426-435
- CountryChina
- Language:English
-
Abstract:
Although intestinal microbiome have been established as an important biomarker and regulator of cancer development and therapeutic response, less is known about the role of microbiome at other body sites in cancer. Emerging evidence has revealed that the local microbiota make up an important part of the tumor microenvironment across many types of cancer, especially in cancers arising from mucosal sites, including the lung, skin and gastrointestinal tract. The populations of bacteria that reside specifically within tumors have been found to be tumor-type specific, and mechanistic studies have demonstrated that tumor-associated microbiota may directly regulate cancer initiation, progression and responses to chemo- or immuno-therapies. This review aims to provide a comprehensive review of the important literature on the microbiota in the cancerous tissue, and their function and mechanism of action in cancer development and treatment.
